• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION/TERUMO BCT IMUFLEX BLOOD BAG SYSTEM; IMUFLEX WB-RP BLOOD BAG SYSTEM WITH LR FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION/TERUMO BCT IMUFLEX BLOOD BAG SYSTEM; IMUFLEX WB-RP BLOOD BAG SYSTEM WITH LR FILTER Back to Search Results
Catalog Number 1BBWGQ506A2
Device Problem Material Integrity Problem (2978)
Patient Problem Hemolysis (1886)
Event Date 05/07/2015
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Investigation: per the customer, the units were processed and the alleged hemolysis was observed in the plasma post centrifugation.The disposable sets were not returned for evaluation.The manufacturing records, test records and inspection records were reviewed for this lot.No anomalies were noted and the product conformed to current established specifications.No similar reports have been received regarding this lot number.Three retention samples from this production number were visually examined.One bag was tested for solution volume and the other two were tested for the composition of the solution.There were no abnormalities in appearance and measured values conformed to in-house standards.Investigation of the manufacturing change control history for the past two years confirmed that the specification for the cationizing agent had been increased.This change had been implemented, to allow greater stability in production.Hemolysis testing was performed to investigate the impact of the cationizing agent.Investigation results indicate that the cationization level of the filter which was integrated into the sterilized product increased and the concentration of free hemoglobin in whole blood increased.The distribution width of the cationization level of actual filters were reviewed and found that it was possible that the width of the cationization level of actual filters is causing the hemolysis the control method of the average cationization level was changed to a new control method.Root cause:the following root causes were determined:-as a result of the increase in the amount of the cationizing agent, the cationization level of the filter which was integrated into the sterilized product, increased.-the distribution width of the average cationization level of the combination of filter membranes was wide and showed some filter membranes of which the average cationization level was high.Corrective action:the following corrective actions were implemented:-the amount of the cationizing agent was restored to the previous manufacturing specifications.-a new filter control method was created, and the control criteria of the average cationization levels was reduced.
 
Event Description
The customer reported that they had 19 units of plasma derived from whole blood with a red tinge they believe is due to hemolysis.There was not a transfusion recipient or patient involved at the time of whole blood processing,therefore no patient information is reasonably known at the time of the event.Donor (b)(6).The disposable sets are not available for return because they were discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMUFLEX BLOOD BAG SYSTEM
Type of Device
IMUFLEX WB-RP BLOOD BAG SYSTEM WITH LR FILTER
Manufacturer (Section D)
TERUMO CORPORATION/TERUMO BCT
fujinomiya
Manufacturer Contact
glenda o'neill
10810 w. collins ave
lakewood, CO 80215
3032314051
MDR Report Key5070712
MDR Text Key26120123
Report Number1722028-2015-00523
Device Sequence Number1
Product Code CAK
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Report Date 08/19/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/11/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2017
Device Catalogue Number1BBWGQ506A2
Device Lot Number141125KK
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/19/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-